Form 4 for RYTM RHYTHM PHARMACEUTICALS, INC.
Accepted 2025-02-14 00:00:00 ET · period of report 2025-02-12 · accession 0001104659-25-014257 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-02-14 | 2025-02-12+ | RYTM | Lee Jennifer Kayden | EVP, Head of North America | S - Sale | $57.03 | -3,020 | 3,598 | -46% | -$172.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-13 | S | D | 1,205 | $58.00 | 2,393 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-12 | S | D | 600 | $56.39 | 4,813 | D | — | — | |
| 3 | Common | Common Stock | 2025-02-12 | S | D | 10 | $56.41 | 4,803 | D | — | — | |
| 4 | Common | Common Stock | 2025-02-12 | S | D | 1,205 | $56.39 | 3,598 | D | — | — |